The Philippine government said Friday it would file criminal charges against six officials of the French pharmaceutical firm Sanofi Pasteur over the deaths of children injected with its Dengvaxia anti-dengue vaccine.
Mar 1, 2019
0
4265
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both ...
Nov 16, 2018
0
0
French pharmaceuticals group Sanofi announced late Monday an immediate halt in production at a chemical factory in southwest France, in the wake of media reports that toxic waste emissions exceeded the norms.
Jul 10, 2018
0
4
The World Health Organization says the first-ever vaccine for dengue needs to be dealt with in "a much safer way," meaning that the shot should mostly be given to people who have previously been infected with the disease.
Apr 19, 2018
0
0
US private equity firm Advent International has agreed to acquire Zentiva, French pharmaceutical giant Sanofi's European generics arm, for 1.9 billion euros ($2.4 billion), a statement said Tuesday.
Apr 17, 2018
0
4
Drugmaker Sanofi insists there's no evidence of a link between the world's first dengue vaccine and children's deaths in the Philippines.
Feb 7, 2018
0
2
French pharmaceutical giant Sanofi on Monday rejected a Philippine government demand to return tens of millions of dollars paid for a dengue vaccine after the programme was suspended over health concerns.
Feb 5, 2018
0
19
Philippine health officials said Friday that the deaths of three children injected with a Sanofi Pasteur dengue vaccine may have "causal association" to the inoculation, including two who may have died because the vaccine ...
Feb 2, 2018
0
6
France's Sanofi announced Monday that it had reached a deal to acquire Belgian biotech firm Ablynx that values the firm at 3.9 billion euros ($4.8 billion), beating out Danish rival Novo Nordisk for the nano-drug maker.
Jan 29, 2018
0
7
French drugmaker Sanofi has made another big purchase aimed at strengthening its position in rare disease treatments, buying Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion).
Jan 29, 2018
0
4
